We are live on ! Find out more
BDSI

BioDelivery Sciences International, Inc.

Delisted

BDSI was delisted on the 22nd of March, 2022.

68 hedge funds and large institutions have $79.9M invested in BioDelivery Sciences International, Inc. in 2018 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

177% more call options, than puts

Call options by funds: $263K | Put options by funds: $95K

30% more capital invested

Capital invested by funds: $61.6M → $79.9M (+$18.4M)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

0% more funds holding

Funds holding: 6868 (0)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

29% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 21

Holders
68
Holders Change
Holders Change %
0%
% of All Funds
1.56%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
15
Reduced
21
Closed
10
Calls
$263K
Puts
$95K
Net Calls
+$168K
Net Calls Change
+$46K
Name Holding Trade Value Shares
Change
Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$361K -$41.9K -17,652 -13%
AC
27
Armistice Capital
New York
$357K -$1.61M -679,111 -85%
D.E. Shaw & Co
28
D.E. Shaw & Co
New York
$257K +$125K +52,738 +153%
OAM
29
Oxford Asset Management
United Kingdom
$249K -$282K -118,817 -59%
State Street
30
State Street
Massachusetts
$238K +$24.3K +10,243 +15%
Citadel Advisors
31
Citadel Advisors
Florida
$229K +$147K +61,820 +392%
NFG
32
Next Financial Group
Texas
$185K +$9.49K +4,000 +7%
Wells Fargo
33
Wells Fargo
California
$157K -$33.6K -14,156 -21%
PNC Financial Services Group
34
PNC Financial Services Group
Pennsylvania
$148K +$119K +50,000 New
Bank of Montreal
35
Bank of Montreal
Ontario, Canada
$138K +$112K +47,096 New
Bank of New York Mellon
36
Bank of New York Mellon
New York
$131K -$19.6K -8,278 -16%
ACS
37
Archford Capital Strategies
Illinois
$118K
Janney Montgomery Scott
38
Janney Montgomery Scott
Pennsylvania
$116K -$4.96K -2,090 -5%
VF
39
Virtu Financial
New York
$113K -$20.6K -8,692 -18%
VNA
40
Valley National Advisers
Pennsylvania
$111K
CCB
41
Cutter & Co Brokerage
Missouri
$105K -$8.3K -3,500 -9%
Barclays
42
Barclays
United Kingdom
$93K -$49.6K -20,912 -40%
FCMI
43
Foresite Capital Management II
California
$90K +$72.3K +30,500 New
Goldman Sachs
44
Goldman Sachs
New York
$88K -$69.9K -29,494 -50%
FCMI
45
Foresite Capital Management III
California
$58K -$309K -130,504 -87%
QSS
46
Quantitative Systematic Strategies
Florida
$57K +$45.5K +19,173 New
WAM
47
Weiss Asset Management
Massachusetts
$50K -$65.7K -27,700 -62%
UBS Group
48
UBS Group
Switzerland
$43K -$11.5K -4,842 -25%
CAM
49
Close Asset Management
United Kingdom
$37K
CPIG
50
Chicago Partners Investment Group
Illinois
$26K

BDSI Hedge Fund Activity: Q2 2018 in Review

68 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in BioDelivery Sciences International, Inc. (BDSI) for Q2 2018, worth a combined $79.9M — up 30% from $61.6M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new BDSI positions and 10 closed out — a net gain of 1 holder — while 15 added to existing stakes and 21 trimmed.

The largest buyer was Cortina Asset Management, opening a new position worth an estimated $4.52M. The largest seller was Stonepine Capital Management, cutting an estimated $5.26M.

  • 68 institutional investors held BioDelivery Sciences International, Inc. (BDSI) as of Q2 2018, unchanged from Q1 2018.
  • Funds reported $79.9M of BioDelivery Sciences International, Inc. stock for Q2 2018, up 30% quarter-over-quarter.
  • 11 funds opened new BioDelivery Sciences International, Inc. positions in Q2 2018 and 10 closed out, a net change of +1 holder.
  • The largest BioDelivery Sciences International, Inc. buyer in Q2 2018 was Cortina Asset Management, an estimated $4.52M added.
  • The largest BioDelivery Sciences International, Inc. seller in Q2 2018 was Stonepine Capital Management, an estimated $5.26M sold.

Based on aggregated 13F filings for Q2 2018.